Carnegie Mellon University »

Carmell Therapeutics Corp - US shares owned by Carnegie Mellon University

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Carnegie Mellon University from 13F filings

Historical chart of Carnegie Mellon University investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Carnegie Mellon University consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Carnegie Mellon University

Quarter filed Position value Share count Share price at filing
2024-06-30 $137k 103k 1.33
2024-03-31 $264k 103k 2.56
2023-12-31 $393k 103k 3.81
2023-09-30 $371k 103k 3.60

More positions owned by Carnegie Mellon University

Duolingo Cl A Com (DUOL)
Carmell Therapeutics Corp - US (CTCX)
Innsuites Hospitality Trust Sh Ben Int (IHT)
Predictive Oncology (POAI)

View all positions for Carnegie Mellon University

Top funds holding Carmell Therapeutics Corp - US

Hubbell Strickland Wealth Management
Vanguard Group
Carnegie Mellon University
Geode Capital Management
BlackRock
Northern Trust
Warberg Asset Management
OZ Management
BlackRock
Bangor Savings Bank
Commonwealth Equity Services
St. Denis J. Villere & Co
Tower Research Capital
Morgan Stanley
Bank of America Corporation

View all funds holding Carmell Therapeutics Corp - US